Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 References  





2 External links  














Cinolazepam






Deutsch
فارسی
Français
Galego
Igbo
Italiano
Magyar
Português
Română
Српски / srpski
Srpskohrvatski / српскохрватски
Suomi
Tiếng Vit

 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Cinolazepam
Clinical data
Trade namesGerodorm
AHFS/Drugs.comcinolazepam
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • US: Unscheduled
Pharmacokinetic data
Bioavailability90–100%
MetabolismHepatic
Elimination half-life3.8 hours[1]
ExcretionRenal
Identifiers
  • (RS)-3-[9-Chloro-6-(2-fluorophenyl)-4-hydroxy-3-oxo-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-2-yl]propanenitrile

CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H13ClFN3O2
Molar mass357.77 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • FC1=CC=CC=C1C2=NC(C(N(CCC#N)C3=C2C=C(C=C3)Cl)=O)O

  • InChI=1S/C18H13ClFN3O2/c19-11-6-7-15-13(10-11)16(12-4-1-2-5-14(12)20)22-17(24)18(25)23(15)9-3-8-21/h1-2,4-7,10,17,24H,3,9H2 checkY

  • Key:XAXMYHMKTCNRRZ-UHFFFAOYSA-N checkY

 ☒NcheckY (what is this?)  (verify)

Cinolazepam[2] (marketed under the brand name Gerodorm)[3] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as a hypnotic.

It was patented in 1978 and came into medical use in 1992.[4] Cinolazepam is not approved for sale in the United States or Canada.

References

[edit]
  1. ^ "ZUSAMMENFASSUNG DER MERKMALE DES ARZNEIMITTELS" (Press release). (inAustrian German). Austria: G.L. Pharma GmbH. Bundesamt für Sicherheit im Gesundheitswesen. October 2018. Archived from the original on 2019-01-02. Retrieved 2019-01-02.
  • ^ US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
  • ^ Lannacher Romania (1999). "Gerodorm". Produse Gerot inregistrate in Romania (in Romanian). Archived from the original on 11 October 2006. Retrieved 17 August 2006.
  • ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 530. ISBN 9783527607495.
  • [edit]
  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Cinolazepam&oldid=1215461820"

    Categories: 
    Secondary alcohols
    Benzodiazepines
    Chloroarenes
    Fluoroarenes
    Hypnotics
    Lactams
    Nitriles
    Sedative stubs
    Hidden categories: 
    CS1 Romanian-language sources (ro)
    Articles with short description
    Short description matches Wikidata
    Articles with changed EBI identifier
    Drugboxes which contain changes to verified fields
    Drugboxes which contain changes to watched fields
    All stub articles
     



    This page was last edited on 25 March 2024, at 07:55 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki